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1INTRODUCTION
  Coronary artery calcification (CAC) occurs in small amounts in the
early lesions of atherosclerosis that appear in the second and third decades of
life, but it is found more frequently in advanced  lesions and in older age.
            Coronary arterial calcification is part of the development of
atherosclerosis, occurs almost exclusively in atherosclerotic arteries, and is
absent in the normal vessel wall
 A positive CT study (defined as presence of any CAC) is nearly 100%
specific for atheromatous coronary plaque. Since both obstructive and non-
obstructive lesions can have calcification present in the intima, CAC is not
specific for obstructive coronary disease.
The site and the amount of coronary artery calcium and the percent of
coronary luminal narrowing at the same anatomic site, the relation is nonlinear
and has large confidence limits. As the occurrence of calcification reflects an
advanced stage of plaque development, some researchers have proposed that the
correlation between coronary calcification and acute coronary events may be
suboptimal based largely on angiographic series5.
              In order to understand this apparent conflict between the stability of a
calcified lesion and CHD event rates, one must recognize the association
1)   Intima            2) Media    3) Adventitia
Atherosclerotic Hardening of the Artery
showing Plaque with Calcification
2between atherosclerotic plaque extent and more frequent calcified and non-
calcified plaque6.
That is, patients who have calcified plaque are also more likely to have
non-calcified or "soft" plaque that is prone to rupture and acute coronary
thrombosis 6.
PATHOPHYSIOLOGY OF CORONARY CALCIFICATION
                 Calcium is a well known component of the atherosclerotic plaque
calcification of atherosclerotic plaque occurs by means of an active process
resembling the bone formation under the control of complex cellular pathways .a
large number of invitro studies have highlighted the importance of calcium in the
process of vascular calcification of osteoblast like cells, cytokines, transcription
factors, and bone morphogenic proteins found in the  normal bone.
               Calcification of the intima is characterized by cellular apoptosis,
inflammation, lipoprotein, phospholipid accumulation, and finally hydoxyapatite
deposition. Calcification is first noticed in the lipid core of the atheroma juxtaposed to
the inflammatory cells that infiltrate the fibrocalcific plaque.
       The basic mechanism initiating the process of calcification is  unknown,
but it seems to require apoptosis of intralesional cells, likely the smooth muscle
cells. The apoptotic bodies would then work as nucleating foci of calcification.
3a.      The CAC score is age and gender specific and therefore there has to be a
comparison of the individual data to a normal cohort in order to produce
meaningful data, usually presented as the percentile distribution. In general,
CAC develops 10 to 15years later in life in women than in men. Similarly
CAC is generally 5 to 7 times lower at any given age in women than in men.
b.  In patients at intermediate clinical risk for coronary events the CAC score can
help to reclassify patients to a higher or lower risk group. For instance a CAC
score of zero confirms low risk of events. Conversely a CAC score of greater
than 400 is observed with a significant cardiac event rate in patients who
appear to be intermediate risk by Framingham score.
c. Because statins have no documented effect on CAC progression, there is no
value in repeating CAC in persons with a score of greater than 100 or the 75
percentile.
d. More  common  in  men,  diabetics  and  renal  failure  pts.   The  role  of  CAC
scoring in determining risk in patients with CKD and/or ESRD is unclear due
to a limited number of clinical studies in these populations.
Some studies suggest that patients with CKD and ESRD develop calcification
in the tunica media layer of the arterial wall, unlike the typical intimal calcification
that is known to be associated with plaque burden. The role of medial calcification as
a marker of cardiovascular risk is not well defined. Some studies reveal an association
4between coronary calcium and prevalent cardiovascular disease in patients undergoing
dialysis and coronary calcium score is associated with risk for total mortality19 .
Principles of Computed Tomography:
Computed tomography (CT) imaging was introduced in 1972. The ability to
obtain cross sectional images of the body revolutionized medicine and, for the
development of computer assisted tomography, Sir Geoffrey N. Hounsfield and Allan
M. Cormack were awarded the Nobel Prize in Medicine in 1979.
            CT is an x-ray–based technique. An x-ray source that rotates on a circular path
around the patient emits a fan-shaped beam of x-rays that passes through the body.
Collimators are used to confine the x-ray beam to the slice that  shall  be imaged; its
thickness can vary from less than one to several millimeters. Opposite the x-ray
source, extremely sensitive detectors record the intensity of x-rays that have passed
through the body. Based on the x-ray attenuations obtained from a multitude of
angles, a cross-sectional image of the body can be calculated.
5Figure 1-1 showing normal cardiac anatomy as depicted by contrast-enhanced
multidetector computed tomography
A, Level of the ascending aorta (Ao) andpulmonary artery, usually the topmost level
of a cardiac CT image data set.
6B, Level of the left main coronary artery(LM), which can be seen originating from the
aortic root and dividing into the left anterior descending coronary arteryand left
circumflex coronary artery (arrow).
C, Level of the proximal right coronary artery (RCA).
D, Midventricularlevel.
E, Level of the caudal right atrium. The drainage of the coronary sinus into the right
atrium (RA) can be seen.
F, Level of the distal right coronary artery.
G, Multiplanar reconstruction to create a short axis view.
H, Multiplanarreconstruction to create a four-chamber view.
I, Three-dimensional surface reconstruction, shown from an anterior view. The
coronary arteries can be recognized on the surface of the heart.
CS  =  coronary  sinus;  Dg  =  diagonal  branch;  IVC  =  inferior  vena  cava;  LA  =  left
atrium; LAA = left atrial appendage; LAD = left anterior descending coronary artery;
LCX  =  left  circumflex  coronary  artery;  LV  =  left  ventricle,  OM  =  obtuse  marginal
branch;  Pc  =pericardium;  PA  =  pulmonary  artery;  RA  =  right  atrium;  RV  =  right
ventricle; RVOT = right ventricular outflow tract; SVC = superior vena cava.
7Analysis of Coronary Artery Calcium
         Electron-beam computed tomography (EBCT) and multi-detector computed
tomography (MDCT) are the primary fast CT methods for CAC measurement at this
time. Both technologies employ thin slice CT imaging, using fast scan speeds to
reduce motion artifact.
Thirty to 40 adjacent axial scans usually are obtained. A calcium scoring system
has been devised based on the X-ray attenuation coefficient or CT number measured
in  Hounsfield  units  and the area of calcium deposits. A fast CT study for coronary
artery calcium measurement is  completed within 10 to 15 min, requiring only a few
seconds of scanning time.
          Cardiac computed tomography has been used with increasing frequency in the
United  States  and  other  countries  during  the  past  15 years,  initially  with  the  goal  of
identifying patients at risk of having obstructive coronary artery disease based on the
amount of coronary calcium present.
However, in the past 5 to 10 years, fast CT methods have been used
primarily for 2 purposes: 1) To assist in coronary heart disease (CHD) risk
assessment in asymptomatic patients, and 2) To assess the likelihood of the
presence of CHD in patients who present with atypical symptoms which could
be consistent with myocardial ischemia.
8Table 1 -1 showing significance of age and CAC score.
AGE IN
YEARS
CAC
SCORE
SENSITIVITY
(%)
SPECIFICITY
(%)
NEGATIVE
PREDICTIVE VALUE
FOR ZERO SCORE(%)
40 to 49 50 71 91 98
50 to 59 50 74 70 94
50 to 59 300 74 81 100
Agatston Coronary Artery Calcium Scoring system:
The agatston coronary calcium volume score is the most frequently used
scoring system. It is derived by measuring the area of each calcified coronary lesion
and multiplying it by a coefficient of 1 to 4, depending on the maximum CT
attenuation within that lesion. It is important to realize the reproducibility of the
agatston score before applying the recommended guidelines for cut points.
Importantly the variability in score has very little meaning at the very high and very
low scores. Inter-reader variability can be as high as 3%17 .
a. The CAC score can be classified in to five groups.
 1) 0 - No coronary calcification
2)  upto 100 - Mild coronary calcification
93) 100 to 399 - Moderate calcification
4)  400 to 999 - Severe calcification
5)  >1000 - Extensive calcification.
Detection of Coronary Artery Calcification
                 The standard EBCT imaging protocol is to acquire 40 consecutive 3-mm-
thick images at a rate of 100 ms per image from the base of the heart to just below the
carina. Images are obtained at end-inspiration, with ECG triggering typically at 80
percent of the R-R interval (end-diastole). Image pixel size using a 512 x 512
reconstruction matrix is 0.26 or 0.34 mm2 based on a 26- or 30-cm field of vision,
respectively.
                  A calcified lesion is generally defined as either two or three adjacent pixels
(0.68 to 1.02 mm2 for a 5122 reconstruction matrix and camera field size of 30 cm) of
>130 Hounsfield  units  (HUs).  Using  the  traditional  Agatston  method,  each  calcified
lesion is multiplied by a density factor as follows: 1 for lesions with a maximal
density between 130 and 199 HU; 2 for lesions between 200 and 299 HU; 3 for
lesions between 300 and 399 HU; and 4 for lesions >400 HU.
             The total coronary artery calcium score (CACS) is calculated as the sum of
each calcified lesion in the four main coronary arteries over all the consecutive
tomographic slices. The EBCT-derived CACS correlates well with calcified areas
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found in individual coronary arteries as determined by histomorphometric
measurements (r = 0.96, p <0.0001)16.
MULTIROW DETECTOR COMPUTED TOMOGRAPHY:
             Advancements in CT technology have improved image acquisition speed and
patient throughput. Multidetector computed tomography (MDCT) scanners produce
images  by  rotating  an  x-ray  tube  around  a  circular  gantry  through  which  the  patient
advances on a moving couch. Increased numbers of detectors have allowed much
faster throughput, essentially reducing the time to image the entire cardiac anatomy to
<10 seconds.
                 The introduction of multirow spiral CT detector systems (i.e., multislice
CT) currently allow acquisition of 4 to 64 simultaneous images,  with slice thickness
reduced to 0.5 to 0.625 mm. Improvements in gantry rotation speeds and the
development of partial reconstruction algorithms have reduced effective single-image
acquisition time to <200 msec.
                  However, image acquisition within 50 ms is required to completely avoid
cardiac motion artifacts. The coronary arteries also move independently throughout
the cardiac cycle and even at slow heart rates (i.e., <70 beats/min) exhibit significant
translational motion of up to 60 mm/sec for the right coronary artery (RCA) and 20 to
40 mm/sec for the left anterior descending (LAD) and circumflex coronary arteries44.
11
                Retrospective gating with MDCT employs acquisition of multiple images
throughout each cardiac cycle. With multirow detector CT systems, temporal
resolution may be further improved by selecting specific partial image sector data
from different heartbeats and detector rings to reconstruct a complete 240-degree
image data set. With retrospective gating, several hundred images can be acquired
during a single cardiac study, allowing one to pick and choose images with the least
amount of motion-related distortion prior to final image reconstruction. However, this
oversampling leads to significant excess radiation exposure to the patient.
                The typical radiation exposure from an electron-beam computed
tomography (EBCT) study is <1.0 rad, whereas MDCT scanners using retrospective
gating can increase exposure approximately 13-fold.44
 Prospective gating during either spiral or nonspiral acquisitions employs
image triggering only at a specific temporal location of the cardiac cycle, thereby
significantly reducing radiation exposure.  Gating works relatively well  at  slow heart
rates (i.e., <60 beats/min), where the R-R interval is >1000 ms and the fastest
imaging protocols are used. However, at faster heart rates, a 200-msec acquisition
effectively covers most of the cardiac cycle, thus obviating any potential benefit from
gating the image acquisition
          MDCT imaging protocols vary among different camera systems and
manufacturers. Generally 40 consecutive 2.5- to 3-mm-thick images are acquired per
cardiac study. Calcified lesions are defined as two or three adjacent pixels with a
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tomographic  density  of  either  >90  or  >130  HU.  Effective  pixel  size  for  a
reconstruction matrix of 512 x 512 pixels with a common field of view of 26 cm is
0.26 mm2. Calcium scoring is usually based on the traditional Agatston method (i.e.,
initial density of >130 HU). As with EBCT scoring, the total CACS is calculated as
the sum of each calcified plaque over all the tomographic slices.
Multirow Detector Computed Tomography compared to Electron Beam
Computed Tomography:
                     The comparability of MDCT- and EBCT-derived coronary artery
calcium scores has been explored in separate studies involving approximately 400
patients.17–19 The MDCT protocols vary considerably in these studies, ranging from
conventional CT to single-slice CT (with either retrospective or prospective gating) to
multislice CT .
                EBCT imaging was performed using the standard protocol conventionally
used in routine clinical practice. Coronary calcification was defined as >130 HU for
EBCT but varied from 90 to 130 HU for MDCT. Although high correlation
coefficients were reported between EBCT and MDCT CACS, there was significant
variability in individual CACS results (range 17 to 84 percent).
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Table 1-2 EBCT versus Mechanical CTa
Author Year Number
of
Patients
Age Average
Ca2+
Score
Mechanical
CT
Technique
Gating Number
of
Detectors
Correlation
Coefficient
Mean %
Difference
Becker20 1999 50 61 983 Nonspiral No Single 0.98 42%
Budoff17 2001 33 54 52 Nonspiral No Single 0.68 84%
Knez19b 2002 99 60 722 Spiral Prosp 4 0.99 17%
Ca2+, calcium; CT, computed tomography; EBCT, electron-beam computed
tomography; prosp, prospective; retrosp, retrospective.
aAgatston score except as indicated. bVolumetric score.
A more recent study by Knez and coworkers compared MDCT to EBCT using
prospective ECG gating for both techniques.19 The  CACS  was  calculated  using  the
volumetric (rather than the Agatston) calcium scoring method.
             Variability in CACS between the two techniques ranged from 20 percent
(CACS <100) to 15 percent (CACS >100), with a mean variability of 17 percent.
Further research is still needed to determine which MDCT technique, imaging
protocol, calcium criterion, and scoring system best approximates the values
determined by EBCT, especially with the new 64-detector systems. No calcium data
is yet available from these state of the art scanners.
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Coronary Artery Calcification and Atherosclerotic Plaque burden:
            The presence of CAC is clearly indicative of coronary atherosclerosis.25,26
Furthermore, the CACS severity, as assessed by EBCT, is directly related to the total
atherosclerotic plaque burden present in the epicardial coronary arteries.25,26 Coronary
calcification is thought to begin early in life, but it progresses more rapidly in older
individuals who have further advanced atherosclerotic lesions.27
            Calcification is an active, organized, and regulated process occurring during
atherosclerotic plaque development where calcium phosphate in the form of
hydroxyapatite precipitates in atherosclerotic coronary arteries in a similar fashion as
observed in bone mineralization.28–30 Although lack of calcification does not
categorically exclude the presence of atherosclerotic plaque, calcification occurs
exclusively in atherosclerotic arteries and is not found in normal coronary arteries.
                The presence and extent of histologically determined plaque area has been
compared to the total calcium area as assessed by EBCT in individual coronary
arteries derived from autopsied hearts.25 A strong linear correlation exists between
total coronary artery plaque area and the extent of CAC as found in individual hearts
(r = 0.93, p < 0.001) and in individual coronary arteries (r = 0.90, p < 0.001).
However, the total calcium area underestimates total plaque area, with approximately
five times as many noncalcified as calcified plaques.25
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Table 1-3 showing accuracy of EBCT Coronary Artery Calcification in Detecting
Significant (>50%) Coronary Artery Stenosis as Defined by Angiography
Investigator Year Number
of
Subjects
Sensitivity
(%)
Specificity
(%)
Positive
Predictive
Accuracy
Negative
Predictive
Accuracy
Agatston17 1990 584 96 51 31 98
Budoff43 1996 710 95 44 72 84
Detrano1 1996 491 95 31 51 89
Baumgart36 1997 57 97 21 56 86
Schmermund3 1997 118 95 88 99 58
EBCT, electron-beam computed tomography.
Coronary Artery Calcification and Stenosis severity:
Significant (>50 percent) coronary artery stenosis by angiography is almost
universally associated with the presence of coronary artery calcium as assessed by
EBCT. However, the severity of angiographic coronary artery stenosis is not directly
related to the total CACS. A recent study compared calcium extent to coronary artery
luminal diameter stenosis determined by morphologic examination of 723 coronary
artery segments.26
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               Although coronary stenosis severity increased with increasing CAC, this
relationship was poor and could not be used to estimate angiographic stenosis severity
on  a  segment-by-segment  basis.  One  explanation  is  that  coronary  artery  remodeling
occurs with increasing plaque burden so as to maintain luminal diameter and arterial
patency.31 Although the extent of coronary calcification does not precisely predict
stenosis severity, noncalcified plaques are almost universally associated with <50
percent diameter stenosis and typically <20 percent stenosis.26 These data indicate that
lack of coronary calcification predicts a very low likelihood of obstructive CAD.
                   Clinical angiographic trials confirm the relationship between CACS
severity and the presence of significant (50 percent) CAD.32 Although the diagnostic
accuracy of EBCT improves with age, most patients younger than 50 years with
obstructive CAD also have coronary calcification (85 percent).33, To date there are 15
studies evaluating EBCT with coronary angiography in which obstructive CAD was
defined as >50 percent luminal diameter stenosis32.
                 In these studies, the overall sensitivity and specificity for detecting
obstructive CAD were 97 and 39 percent, respectively. In the largest series, Haberl
and colleagues performed EBCT within 30 days of coronary angiography in 1764
patients who had suspected CAD.41 Only 5 of 940 patients (0.5 percent) with
significant (50 percent) coronary artery stenosis had a normal EBCT, and four of
these were younger than 45 years of age. Although differences in CACS were noted
among men and women, EBCT predicted CAD equally well in both genders, based on
17
age-specific CACS thresholds.41 Coronary artery calcification (CAC) assessment may
also be useful for detecting CAD in heart transplant recipients.4
                   The poor specificity of coronary calcium scanning can be reconciled by
the fact that the coronary calcification confirms the presence of atherosclerotic plaque
but it may not necessarily be obstructive.. The CACS severity may be a better
barometer of obstructive CAD than the mere presence of calcium.
                 Budoff and coworkers observed that specificity increased with the number
of calcified coronary arteries (i.e., high calcium scores).33 Two separate reports in
patients referred for coronary angiography found that a CACS >100 best predicted
obstructive CAD with an equally high sensitivity and specificity of 80 percent.
              There appears to be a threshold CACS above which most patients will have
significant coronary artery stenosis. The accuracy for identifying significant CAD
based on CACS may be further improved by incorporating age, gender,39 and
traditional risk-factor information. However, despite the relationship between
obstructive CAD and CACS severity, the latter is still too imprecise in itself to be
used as a definitive criterion for proceeding directly to coronary angiography.
                   The current American College of Cardiology/American Heart Association
(ACC/AHA) guidelines on coronary angiography do not recommend coronary
angiography on the basis of a positive EBCT but do suggest angiography may be
avoided with the finding of a negative (zero score) study
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Prognosis by Coronary Artery Calcium Measurements:
             In the prior ACC/AHA expert consensus document published in 2000, only 3
reports on the prognostic capability of CAC scoring were available to develop risk
assessment indications in asymptomatic individuals. At the time, the ACC/AHA
document concluded that  the  body  of  evidence  using  CAC  measurement  to  predict
CHD events was insufficient7.
          A critical component to that recommendation was that the independent
prognostic value of CAC had not been established. In a separate but similar evaluation
using data published through 2002, the U.S. Preventive Services Task Force
(USPSTF) concluded that limited clinical outcomes data were available and
recommended against routine screening for the detection of silent but severe CAD or
for the prediction of CHD events in low risk, asymptomatic adults.
          In the past several years, however, a number of publications have reported on
the  incremental  prognostic  value  of  CAC  in large series of patients including
asymptomatic self-referred and population cohort.
       A major rationale for the current document is the need for an update including
recent publications regarding CAC as it relates to the estimation of CHD death or
nonfatal myocardial infarction (MI).
         Although earlier evidence included the use of "soft" endpoints including
coronary revascularization as a primary outcome, more recent data are available on the
19
estimation of CHD death or MI. Models predicting "hard" cardiac events (i.e., CHD
death or MI) are less subjective and less likely to overestimate the predictive accuracy
of CAC scoring.
Other Uses:
1. To differentiate between ischemic and non ischemic cardiomyopathy. One
large study in 120 patients with heart failure of unknown etiology
demonstrated the  presence  of  CAC  was  associated  with  99%  sensitivity  for
ischemic cardiomyopathy.  Another study also demonstrated similarly high
sensitivity using fast CT to differentiate ischemic from non-ischemic
cardiomyopathy 11
2. To triage chest pain patients in Emergency Department.
 3.  Presence  of  any  calcium –  There  is  a  fourfold  risk  of  coronary  events  in  the
next 3 to  5 years.
 4. To reclassify intermediate risk group to either low or high risk group based on
Framingham risk score. The accumulating evidence suggests that
asymptomatic individuals with an intermediate FRS may be reasonable
candidates for CHD testing using CAC as a potential means of modifying risk
prediction and altering therapy. On the other hand, there is little to be gained
20
  by testing with CAC in patients with a low FRS. Furthermore, patients with a
high FRS should be treated aggressively consistent with secondary prevention
goals based upon the current NCEP III guidelines and thus should not require
additional testing, including CAC scoring, to establish this risk evaluation 13.
5. Statins has no effect on CAC progression if score is more than 100.
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AIM OF THE STUDY
? To compare CAC (coronary artery calcium) score in patients with
Obstructive and Non obstructive CAD.
? To compare CAC score in patients with single and multivessel disease.
? To compare CAC score in males and females.
? To  compare  CAC  score  in  those  with  and  without  HT,  Smoking  and
Diabetes.
? To compare CAC score between IRA and other vessels in multivessel
disease.
22
REVIEW OF LITERATURE
Theoretical relationship between Coronary Calcification and CHD events:
            There are conflicting results regarding the site, extent of coronary artery
calcification and the angiographic grading based on various available data.
Atherosclerotic plaque proceeds through progressive stages where instability and
rupture can be followed by calcification, perhaps to provide stability to an unstable
lesion.
          As the occurrence of calcification reflects an advanced stage of plaque
development, some researchers have proposed that the correlation between coronary
calcification and acute coronary events may be suboptimal based largely on
angiographic series.
There is no known relationship between vulnerable plaque and coronary
artery calcification3. The relation of arterial calcification, like that of
angiographic coronary artery stenosis, to the probability of plaque rupture is
unknown4.
Although radiographically detected coronary artery calcium can provide
an estimate of total coronary plaque burden, due to arterial remodeling, calcium
does not concentrate exclusively at sites with severe coronary artery stenosis 5.
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It is the co-occurrence of calcified and non-calcified plaque that
provides the means for estimating acute coronary events. Furthermore, although
CAC detection cannot localize a stenotic lesion or one that is prone to rupture,
CAC scoring may be able to globally define a patient’s CHD event risk by
virtue of its strong association with total coronary atherosclerotic disease
burden, as shown by correlation with pathologic lesions.
 The Committee judged that it may be reasonable to consider use of CAC
measurement in such patients based on available evidence that demonstrates
incremental risk prediction information in this selected (intermediate risk)
patient group. This conclusion is based on the possibility that such patients
might be reclassified to a higher risk status based on high CAC score, and
subsequent patient management may be modified9.
          In order to understand this apparent conflict between the stability of a
calcified lesion and CHD event rates, one must recognize the association
between atherosclerotic plaque extent and more frequent calcified and non-
calcified plaque. That is, patients who have calcified plaque are also more
likely to have non-calcified or "soft" plaque that is prone to rupture and acute
coronary thrombosis.
         A subset analysis of the predictive accuracy of CAC in patients with an
intermediate FRS reveals that for a score greater than or equal to 400, the patient’s 10-
year CHD risk would achieve risk equivalent status similar to that noted with diabetes
24
or peripheral arterial disease . Thus, clinical decision-making could potentially be
altered by CAC measurement in patients initially judged to be at intermediate risk
(10% to 20% in 10 years)12.
                  Most unexpected cardiovascular events occur in persons at intermediate
risk of coronary artery disease (10%–20% 10-year risk). The absence of CAC by
cardiac CT is associated with a low adverse event risk and therefore could be used as
a tool to counsel patients about their risk of such events13.
Coronary artery scanning using electron beam computed tomography is a
diagnostic tool with application to high-risk and symptomatic subjects that can assist
in diagnosing or excluding coronary artery disease. Although there is ample evidence
for the utility of this and related technologies for diagnosis in symptomatic subjects,
this remains an unproven technology for screening healthy asymptomatic subjects1
             Multiple logistic regression analysis determined male sex, presence of
diabetes and left anterior descending (LAD) and circumflex (LCX) coronary calcium
scores, independent from more distal calcium localization, as independent predictors
for identification of three-vessel and/or left main CAD2.
               On the basis of a simple algorithm ("noninvasive index"), EBCT calcium
scanning in conjunction with risk factor analysis can rule in or rule out
angiographically  severe  disease,  i.e.,  three-vessel  and  or  left  main  CAD,  in
symptomatic patients2.
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On average, significant coronary disease (greater than 50% or greater than
70% stenosis by coronary angiography) was reported in 57.2% of the patients.
Presence of CAC was reported on average in 65.8% of patients (defined as a score
greater than 0 in all but one report)
              Higher coronary calcium scores increased the likelihood of detecting
significant coronary disease (greater than 50% or greater than 70% luminal stenosis).
A threshold of detectable calcium or a score greater than  5  was  associated  with  an
odds of significant disease of 25.6-fold (95% CI 9.6 to 68.4)1.
Because of its potential in this regard, further research should be encouraged
to determine its place in the armamentarium of diagnostic tools. In contrast to its
unproven utility for screening asymptomatic populations, electron beam computed
tomographic coronary calcium has shown fairly accurate association with coronary
angiographic findings in symptomatic patients referred for angiography for chest pain
syndromes1.
             MESA STUDY -  The Multi Ethnic Study of Atherosclerosis  (6800 subjects)
has reported that all modern Multi Detector Row CT systems are at least as reliable as
EBCT for performing and reproducing coronary calcium measurements 1.
            From the ST. FRANCIS HEART STUDY, measured risk factor data were
available in 1293 of the total enrolled cohort of 4903 asymptomatic individuals. In
univariable (p less than 0.0001) and multivariable (p = 0.01) models estimating CHD
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events at 4.3 years of follow-up, CAC scores were independently predictive of CHD
outcome above and beyond both historical and measured risk factors37.
RECALL STUDY- The Heinz-Nixdorf Risk factors Evaluation of Coronary
Calcium, and Lifestyle study (4200 subjects) provides unbiased information on the
extent  of  coronary  calcium  in  the  general  German  population  from  a  suburban
community3.
In this study again the coronary calcium score was superior to conventional
risk factors for predicting coronary heart disease. This was true even for all four major
racial and ethnic groups in the United States 1.
             Coronary atherosclerotic changes may appear calcified, noncalcified or mixed
plaque lesion. Noncalcified lesions are found predominantly in patients who have
AMI,  whereas  calcified  lesions  are  found  more  often  in  patients  who  have  chronic
stable angina 14.
            The CT density of noncalcified plaques is significantly lower in the culprit
coronary segment of patients studied at the time of acute coronary syndromes as
compared with those who have chronic stable disease15.  In  patients  who  have  an
acute   coronary   syndrome,  a   noncalcified   lesion   in  the  coronary   artery   may
correspond  to an intracoronary thrombus16.
          The current gold standard to detect coronary atherosclerosis in vivo is
intravascular ultrasound (IVUS).studies comparing IVUS with multidetector row
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CT (MDCT) have shown a good correlation between the echogenicity by IVUS and
the CT density of coronary atherosclerotic lesions.
          The sensitivity and specificity for CT to detect calcified and non calcified
coronary atherosclerosis are 78% and 94%, respectively the sensitivity to comparison
between CTA and IVUS is only 52%. However, probably because of the lower spatial
resolution if CTA 18.
Coronary Artery Calcification: Prognostic Implications
The likelihood of plaque rupture and the development of acute cardiovascular
events is related to the total atherosclerotic plaque burden.27 Although controversy
exists as to whether calcified or noncalcified plaques are more prone to rupture28
extensive calcification indicates the presence of both plaque morphologies.7
There is a direct relationship between the CACS severity, the extent of
atherosclerotic plaque, and the presence of silent myocardial ischemia. Many studies
have now demonstrated an increased risk for cardiac events in asymptomatic patients
who have extensive silent myocardial ischemia29. Therefore,  the  CACS  could  be
useful for risk assessment of asymptomatic individuals and potentially guide
therapeutics.
Several recent trials in both symptomatic1 and asymptomatic13 patients have
studied  whether  the  extent  of  CAC  as  assessed  by  EBCT  can  predict  subsequent
patient outcome. In 422 symptomatic patients followed for 30 ± 12 months29 cardiac
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events were 10-fold higher in patients with a CACS above the 75th percentile for age
(9.5 percent) versus those below the 25th percentile (0.9 percent). Another study of
288 symptomatic patients referred for coronary angiography30 showed that patients
with a CACS >100 had a 3.2-fold higher relative risk of death or MI than those with a
lower CACS (95 percent confidence limit: 1.17–8.71).
                In the longest study of EBCT scanning of the coronary arteries, the SOUTH
BAY HEART WATCH STUDY, 1196 asymptomatic patients were followed (median
= 7.0 years) and it was demonstrated that the CACS score added predictive power
beyond that of standard coronary risk factors and C reactive protein.31
                 Among 1173 asymptomatic patients followed for 3.6 years after an initial
screening EBCT,32 no  events  occurred  in  patients  with  a  normal  study  and  the
negative predictive value was 99.8 percent in patients with a CACS <100. These
results show a 5, 7, and 13 percent hard cardiac event rate in individuals with a CACS
80, 160, and 600, respectively.32 The CACS remained the best single predictor of risk
after adjustment. Wong and colleagues also showed that the CACS severity predicted
subsequent events independent of age, gender, and patient risk-factor profile33.
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Table 3-1 Multivariate Analyses of the Association of Coronary Artery Calcium
Scores and Self-Reported Traditional Coronary Disease Risk Factors with
All Eventsa
Variable Odds Ratio (95% CI)
Independent of EBCT Elevated cholesterol 3.9 (1.3–11.7)
Hypertension 2.8 (1.2–6.5)
Diabetes 5.4 (2.0–14.9)
With EBCT CACS 80
CACS >80 14.3 (4.9–42.3)
Age >55 y 3.3 (1.3–8.4)
Elevated cholesterol 4.0 (1.3–12.2)
Hypertension 2.6 (1.1–6.1)
Diabetes 4.8 (1.6–13.9)
With EBCT CACS 160
CACS >160 19.7 (6.9–56.4)
Age >55 y 4.5 (1.6–12.2)
Elevated cholesterol 3.7 (1.2–11.5)
Hypertension 3.0 (1.2–7.4)
Diabetes 5.8 (2.1–19.7)
With EBCT CACS 600
CACS >600 20.2 (7.3–55.8)
Age >55 y 2.9 (1.1–7.9)
Elevated cholesterol 3.5 (1.1–10.8)
Hypertension 2.9 (1.2–7.3)
Diabetes 4.4 (1.4–13.7)
CI, confidence interval; EBCT, electron-beam computed tomography.
aAnalysis were performed with and without the coronary artery calcium scores (CACS)32.
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                Raggi and coworkers reported on 172 patients who had EBCT within 60
days of an unheralded MI and on 632 asymptomatic patients who were referred for a
screening EBCT and then followed for 32 ± 7 months.34 Ninety-six  percent  of  all
patients with infarction were abnormal by EBCT, and the CACS was 100 in 62
percent and 400 in 47 percent of patients.
                  Both the absolute CACS and the relative CACS percentiles adjusted for
age and gender predicted subsequent death and nonfatal MI. Hard cardiac events
occurred in only 0.3 percent of subjects with a normal EBCT, but this increased to 13
percent in those with a CACS >400. A very high CACS 1000 may portend a
particularly high risk of death or MI (i.e., 25 percent per year).35
             Larger trials have been reported, demonstrating approximately 10-fold
increased risk with the presence of CAC. 36 in one of the largest observational trials to
date,
Shaw and colleagues reported all-cause mortality among 10,377 asymptomatic
patients (4191 women and 6186 men) who had a baseline EBCT and were then
followed for 5.0 ± 3.5 years.38 Most subjects had cardiac risk factors including a
family history of CAD (69 percent), hyperlipidemia (62 percent), hypertension (44
percent), and current cigarette smoking (40 percent). The CACS was a strong
independent predictor of mortality (x2 = 36.6, p < 0.00001) with 43 percent additional
predictive value contained within the CACS beyond risk factors alone. Mortality
significantly increased with increasing CACS.
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Similarly, in a younger cohort of asymptomatic persons35 the 3 year mean
follow up in 2000 participants (mean age 43 years) showed that coronary calcium was
associated with an 11.8-fold increased risk for incident coronary heart disease (CHD)
(p < 0.002) in a Cox model controlling for the Framingham risk score.
                 The ROTTERDAM HEART STUDY39 investigated 1795 asymptomatic
participants (mean age 71 years) who had CAC and measured risk factors.  During a
mean follow up of 3.3 years, the multivariate-adjusted relative risk of coronary events
was 3.1 (95 percent CI, 1.2–7.9) for calcium scores of 101 to 400, 4.6 (95 percent CI,
1.8–11.8) for calcium scores of 401 to 1000, and 8.3 (95 percent CI, 3.3–21.1) for
calcium scores >1000 compared with calcium scores of 0 to 100.
                    The COOPER CLINIC STUDY40 included 10,746 adults who were 22 to
96 years of age and free of known CHD. During a mean follow up of 3.5 years, 81
hard events (CHD death, nonfatal MI) occurred. Age-adjusted rates (per 1000 person-
years) of hard events were computed according to four CAC categories: no detectable
CAC and incremental sex-specific thirds of detectable CAC; these rates were,
respectively, 0.4, 1.5, 4.8, and 8.7 (trend p < 0.0001) for men and 0.7, 2.3, 3.1, and 6.3
(trend p < 0.02) for women.
               The association between CAC and CHD events remained significant after
adjustment for CHD risk factors. A Munich Study determined the extent of CAC by
MDCT in 924 patients (443 men, 481 women, aged 59.4 ± 18.7 years).
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             During the 3-year follow-up period, the event rates for coronary
revascularization (5.4 %/y vs. 2.9 %/y), MI (3.8 %/y vs. 1.8 %/y), and cardiac death
(2.1 %/y vs.  1.0 %/y) in patients with volume scores above the 75th percentile were
significantly higher compared to the total study group and no cardiovascular events
occurred in patients with scores of zero. Receiver operating characteristic (ROC)
analysis demonstrated it outperformed both PROCAM and Framingham models (p <
0.0001),  where  36  percent  and  34  percent  of  MIs  occurred  in  the  high  risk  cohorts,
respectively.
Coronary artery calcium score in diabetes population.
                    A study demonstrated the risk stratification in uncomplicated type 2
diabetes in a prospective evaluation of CAC and MPS.42 Risk factors and CAC scores
were prospectively measured in 510 asymptomatic type 2 diabetic subjects (mean age
53 ± 8 years, 61 percent males) without prior cardiovascular disease with a median
follow  up  of  2.2  years.  In  the  multivariable  model,  the  CAC  score  and  extent  of
myocardial ischemia were the only independent predictors of outcome (p < 0.0001).
ROC analysis demonstrated that CAC predicted cardiovascular events with the
best area under the curve (0.92), significantly better than the United Kingdom
Prospective Diabetes Study Risk Score (0.74) and Framingham Score (0.60, p <
0.0001). The relative risk to predict a cardiovascular event for a CAC score of 101 to
400 was 10.13, and increased to 58.05 for scores >1000 (p < 0.0001). No cardiac
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events or perfusion abnormalities occurred in subjects with CAC 10 Agatston units up
until 2 years of follow up.
               The CAC score appears to provide complementary prognostic information to
that  obtained  by  the  Framingham  risk  model.  Combining  EBCT  results  with
biochemical markers, such as C-reactive protein, may more precisely define risk than
either test alone. . More data is needed in different ethnic groups prior to widespread
application.41
Calcium Score and Ethinicity
                  Finally data from the MESA study1 and other series demonstrated that
whites  have  a  higher  prevalence  of  CAC and  CAC scores  than  the  other  races,  and
this raised the question of the validity of CAC in non- whites .Two recent publications
addressed the value of CAC as a marker of risk in four different races (White, African
American, Chinese and Hispanic)in the united states .
Nasir and his colleagues evaluated the use of CAC to predict all cause
mortality (505 deaths during the 10 years follow up) in 14,812 patients .the
prevalence of CAC was higher in whites, although blacks and Hispanics had a greater
clustering of risk factors for CAD.
            Despite a low prevalence of CAC and lower scores compared with other races
, black patients demonstrated the highest mortality rates even after multivariable
adjustment for clinical risk factors and  baselines CAC scores (p,<.0001).compared
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with whites the relative risk for death was 2.97 (95%cl:1.87-4.72) in  blacks ,1.58
(95%cl:0. 92-2.71) in Hispanics and 0.85 (95% cl:0.47-1.54) in Chinese.
            Detrano and his colleagues1 showed that CAC is a strong predictor of  CVD,
non fatal myocardial infraction ,angina and revascularization independent of race in
6722 MESA patients (the risk increased 7.7 fold in patients with a CAC  score
between 101 and 300 compared with 0 and 9.7 fold in patients with a score >300).
Furthermore CAC added incremental prognostic value beyond traditional risk factors
for prediction of all events in all races.
            Hence, CAC seems to be an excellent marker of risk in all races so far
investigated although the prognostic significance of score categories may vary among
the racial groups.
The evidence surrounding the CAC was recently reviewed into two statements
of the American Heart Association12 and the American College Of Cardiology, which
recognized the potential utility of CAC screening for refinement of risk assessment in
intermediate risk peoples.
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MATERIALS AND METHODS.
? This study was conducted in the Department of Cardiology, Government
General Hospital, Chennai, during the year 2009 – 2010.The study is a
prospective observational non interventional study involving 100
patients.
? Ethical committee clearance was obtained to conduct the study in our hospital.
? All subjects provided written informed consent to participate in the study
before inclusion.
Inclusion Criteria:
? All patients following STEMI (MI diagnosed by History, ECG. ECHO &
Enzymes) including both recent and old myocardial infarction irrespective of
age and sex.
? Both thrombolysed & not thrombolysed patients.
? Patients with or without LV dysfunction.
Exclusion Criteria
? All acute coronary syndrome patients.
? All chronic stable angina patients.
? Chronic kidney disease.
? Uncontrolled tachycardia.
? Technically inadequate CT.
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Flow chart showing patient characteristics of the study population.
Total Patients
100
50 patients of
STEMI with
Significant CAD
50 patients of
STEMI without
Significant CAD
Group I
n=50
Group I
n=50
Male - 45 Female - 45 Male - 45 Female - 45
AWMI
28
IWMI/RVMI
22
AWMI
32
IWMI/RVMI
18
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Study Centre
? Department of Cardiology and Department of Radiology- Government
General Hospital, chennai – 3.
Single centre, Prospective Observational, Non-interventional study.
Detailed history was obtained from all the patients, including the presence of
risk factors like
- Diabetes mellitus,
- Hypertension,
- Smoking and
- Family history of ischemic heart disease.
Baseline investigations were done in all patients including complete blood
count, blood sugar, renal function tests, lipid profile, chest X-ray. ECG, ECHO,
Cardiac enzymes, namely, Creatinine kinase and CK-MB were done in all patients.
Patient characteristics:
The study population included 100 patients (91 male and 9 female) admitted to
the department of cardiology  Govt. General Hospital, Chennai – 3, for coronary
angiography evaluation following STEMI.
38
Table 4-1 Showing Patient Characteristics:
Group 1
(n=50)
Group 2
(n=50)
TOTAL
Age < 40 years 7 10 17 (17%)
40 to 60 years 11 5 16 ( 16%)
>60 years 32 35 67 (67%)
Male 46 45 91 (91%)
Female 4 5 9 (9%)
Hypertension 15 10 25 (25%)
Diabetes 8 13 31 (31%)
Smoking 16 5 21 (21%)
F/H of CAD 4 1 5 (5%)
  Our study population contains predominantly male (90%). One fourth of the
population had hypertension and one third of the study group are diabetics.
One fifth are smokers. Only few patients gave history of smoking.
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Coronary Angiography:
?  All patients following STEMI admitted to undergo coronary angiography
(After an average period of 4 to 6 weeks following STEMI) in the department
of cardiology underwent CAG using Philips Integri 3000 machine.
Government General Hospital,Chennai-3.
?  CAG was done through both the femoral and radial route, using properly
sized sheath, Judkin’s catheter, Amplatz catheter and Tiger catheters if
necessary.  Multiple angulations and views were used. The CAG was analyzed
and the lesions are quantified in detail. Lumen diameter narrowing was graded
as 0, 25,50,75,90 and 100%. A detail report with pictures are prepared and
tabulated.
Complications:
Five patients of the study group developed minor complications in the form of
minor hematoma, transient benign arrhythmias. There is no death, MI or CVA in the
study group following the procedure.
Based on CAG findings the study population is categorized into study
 Group I– With obstructive CAD (defined as ?50% luminal obstruction irrespective of
the infarct related artery) and
40
 Group II – With non obstructive CAD (<50% luminal obstruction in any of the
epicardial coronaries as well as normal coronaries).
CAC score measurements:
Then the patients were referred to Barnard Institute of Radiology, Government
General Hospital, Chennai-3 for assessment of CAC score. (Average waiting period
for  CAC  measurement  following  CAG  is  2  weeks).   It  was  done  using  Philips
Brilliance 64 slice MDCT machine based on Agatston scoring system by a expert
radiologist  who has no knowledge about the CAG lesions of the patients concerned.
Any score greater zero is considered as positive score based on agatston scoring
system.  And the  results  of  both  groups  who underwent  CAC scores  were  tabulated,
compared and analyzed in detail.
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RESULTS
Statistical analysis:
The results were analyzed by the following statistical methods.
1) Chi-square test
2)  Mann Whitney U Wilcox on Rank Sum  test
3)  Correlation coefficient methods
4) Multiple regression analysis.
The p values are categorized as follows.
a) 0 to 0.01 - Significant at 1% level.
b) 0.01 to 0.05- Significant at 5% level.
c) > 0.05 - No statistical significance.
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Table 5-1 showing patient’s CAG baseline profile in Group I :
VESSEL
INVOLVEMENT
LAD LCX RCA
LAD &
LCX
LAD &
RCA
LCX &
RCA
LAD,
LCX &
RCA
NO OF CASES 12 3 5 7 14 2 7
Table 5-2 showing Types of MI and the vessels involved.
VESSELS INVOLVED AWMI IWMI / RVMI
LAD 13 1
LCX 0 3
RCA 2 3
LAD & LCX 4 1
LCX & RCA 3 4
LAD & RCA 6 2
LAD,LCX & RCA 6 1
About 90% of AWMI patients showed LAD involvement whereas LCX & RCA are
the predominant culprit vessels among patients with IWMI/RVMI.
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Table 5-3 showing the significance of risk factor and CAC scores in patients in
Group I:
S.No Variable
Positive
CAC
Negative
CAC
p value Significance
1 DIABETES 9 3 0.067 SIGNIFICANT
2 HYPERTENSION 8 7 0.901 NOT SIGNIFICANT
3 SMOKING 11 5 0.103 NOT SIGNIFICANT
4
FAMILY
HISTORY
4 0 0.045 SIGNIFICANT
5 SEX M-24,F-2 M-21,F-3 0.571 NOT SIGNIFICANT
6 AGE
MEAN
50.82
MEAN
48.84
0.025 SIGNIFICANT
The above analysis are done using chi-square test regarding the significance of
the above variable and total CAC score among GROUP 1 patients.
            It showed that though the conventional risk factors like hypertension, smoking
and male sex are associated with increased CAC scores they are not statistically
significant whereas the diabetes, age and positive family history is predictive of
increased CAC scores in patients with obstructive CAD and it is statistically
significant.
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Figure 1 showing risk factor and CAC correlation in GROUP I patients. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 showing risk factor and CAC correlation in GROUP I patients. 
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Table 5-4 showing the significance of risk factor and CAC scores in
patients in Group II:
S.
No
Variable Positive
CAC
Negative
CAC
P
value
Significance
1 DIABETES 5 3 0.119  NOT
SIGNIFICANT
2 HYPERTENSION 1 9 0.041  SIGNIFICANT
3 SMOKING 2 3 0.922 NOT
SIGNIFICANT
4 FAMILY HISTORY 1 0 0.196  NOT
SIGNIFICANT
5 SEX M - 17, F- 2 M – 29, F - 2 0.606 NOT
SIGNIFICANT
6 AGE MEAN
52.84
MEAN
49.12
0.072 SIGNIFICANT
The above analysis is done using chi- square test regarding the significance of
the above variable and total CAC score among GROUP II patients.
                 It showed that though the conventional risk factors like diabetes, smoking,
family history and male sex are associated with increased CAC scores they are not
statistically significant except age which has good correlation with statistical
significance. It was also found that history of hypertension shows negative predictive
value for CAC scores in patients with non obstructive CAG and it is statistically
significant (p- 0.041).
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Table 5-5 showing the significance of individual vessel involvement and CAC
scores in patients in Group II.
S.NO
LAD
CAC
LCX
CAC
RCA
CAC
TOTALCAC P VALUE
1
LAD
CAG
    0.0598
P=0.68   0.0599
P=0.68
0.761
 P=0.6
0.0739
P=0.61
NOT
SIGINIFICANT
2
LCX
CAG
0.0038
P= 0.979
0.1617
P=0.289
0.1529
P=0.289
0.0439
P=0.762
NOT
SIGINIFICANT
3
RCA
CAG
0.0893
P= 0.538
0.075
P = 0.605
0.1718
P = 0.233
0.1204
 P =0.405
NOT
SIGNIFICANT
            A  detailed  analysis  of  CAG  lesions  of  individual  vessel  was  correlated  with
the CAC scores of corresponding vessel in patients among Non obstructive CAD. The
above details  of Group II  comparing CAG with CAC score were analyzed using the
correlation coefficient method and the details revealed no statistical significance.
Thus  it  shows  that  there  is  no  correlation  between  the  CAG  stenosis  and  the  CAC
score of the vessel involved among patients with Non obstructive CAD.
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Table 5-6 showing the significance of individual vessel involvement and CAC
scores in patients in Group I
CAC LAD LCX RCA TOTAL P VALUE
C
A
G
LAD 0.1545
P=0.284
0.0258
P=0.859
0.0161
P=0.912
0.1128
P=0.436
NOT
SIGINIFICANT
LCX 0.0038
P= 0.979
0.1617
P=0.289
0.1529
P=0.289
0.0298
P=0.837
NOT
SIGINIFICANT
RCA 0.0893
P= 0.538
0.075
P = 0.605
0.1718
 P = 0.233
0.1663
P =0.248
NOT
SIGNIFICANT
                A detailed analysis of CAG lesions of individual vessel was correlated with
the CAC score of the corresponding vessel of patients among obstructive CAD. The
above details of Group 1 comparing CAG with CAC score were analyzed using the
correlation coefficient method and the details revealed no statistical significance.
Thus it shows that there is no correlation between the stenosis and the CAC score of
the vessel involved.
Picture -8. Raju  59/M – Old AWMI:
a) CAG – LAD 80% lesion
b) Mid RCA- 70% lesion c) CAC – score 448
Picture -2. Ramachandran 55/M – Old AWMI:
a) CAG – Mid LAD 70% lesion  &  Mid RCA- 70% lesion
 b) CAC – LAD  score is 2.
Picture -3. Ravichandran  50/M – Old AWMI: a) CAG – LAD 80% lesion
 b) Mid RCA- 100% lesion c) CAC – score is zero.
Picture -4. Veeran 27/M – Old AWMI: a) CAG – Normal LCA
b) CAC – score is zero.
Picture -5. Baskar 68/M – Old AWMI: a) CAG – Normal LAD & LCX.
b) CAC – dense calcium in LAD 1573, ,RCA 37.
Picture -6. Perumal  55/M –  Old  IWMI/RVMI: showing  Mid LAD
irregularities with dence calcium in LCA.
Picture -7. Nayanan  62/M –Correction between normal CAG with normal
CAC despite advanced age
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Table 5-8 showing the significance of multivessel involvement and CAC scores in
patients in both groups.
S.NO VESSELS INVOLVED MULTIPLE R SIGNIFICANCE
1 LAD & LCX 0.112 NO
2 LAD & RCA 0.245 NO
3 LCX & RCA 0.166 NO
4 LAD, LCX & RCA 0.250 NO
       The significance of correlation of multivessel involvement and total calcium
scoring was analyzed by multiple regression analysis.  The CAC score was analyzed
between double and triple vessel involvement with single vessel disease. It was found
that there is no increase in either the positivity or the degree of CAC score with
multivessel involvement when compared to single vessel disease.
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DISCUSSION
Our study showed that though the conventional risk factors like hypertension,
smoking and male sex are associated with increased CAC scores, they are not
statistically significant whereas the diabetes, age and positive family history is
predictive  of  increased  CAC  scores  in  patients  with  obstructive  CAD  and  it  is
statistically significant.
Further  it  was  also  found  that  though  the  conventional  risk  factors  like
diabetes, smoking, family history and male sex are associated with increased CAC
scores they are not statistically significant except age which has good correlation and
history of hypertension shows negative predictive value for CAC scores in patients
with non obstructive CAG and it is statistically significant.
Smoking:
A strong dose–response relationship between cigarette smoking and CHD has
been  observed  in  both  sexes,  in  the  young,  in  the  elderly,  and  in  all  racial  groups.11
Cigarette smoking increases risk two- to threefold and interacts with other risk factors
to multiply risk. There is no evidence that filters or other modifications of the
cigarette reduce risk. Pipe smoking and cigar smoking increase the risk of CHD. More
than 1 in every 10 cardiovascular deaths in the world in the year 2000 were
attributable to smoking.25
POSITIVE CAC0
5
10
15
20
25
30
POSITIVE CAC
NEGATIVE CAC
POSITIVE CAC0
5
10
15
20
25
30
POSITIVE CAC
NEGATIVE CAC
 
Figure 3 – Sex distribution in Group I with CAC score. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – Sex distribution in Group II with CAC score. 
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                Smoking does not carry a significant risk for coronary calcification as
compared to international studies .There were 16 patients (32%) in group I and 5
(10%) patients in group II with smoking history. But in both groups smoking does not
show a statistically significant correlation of increased CAC score.( p – 0.103 in
Group I: P-0.922 in Group II)
CAC Scores and Gender:
                Gender differences in utility and accuracy of imaging tests are typically
related to differences in the epidemiology of coronary heart disease, with women
having later onset of clinical CHD than men. Gender differences in incidence and
prevalence of CAD are most marked in middle-aged populations, the typical target age
group for CHD screening. In addition, emerging data suggest that there may be actual
gender differences in the anatomy of atherosclerosis.
               Thus, it is important to consider gender-specific data when evaluating the
potential uses of any new cardiac test. There are limited data broadly specific to
women on the relationship between CHD outcomes and CAC. Existing data confirm
an association between CAC scores and all-cause mortality and CHD events in elderly
women.
              The Prospective Army Coronary Calcium (PACC) Project19 found a higher
prevalence of coronary calcium in white (19.2%) than black (10.3%) active-duty
military personnel with a mean age of 42 years; the difference persisted after adjusting
for cardiovascular disease risk factors.
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            Budoff et al. described similar findings in white men referred for CAC testing
compared with black  men;  however,  in  this  study,  black  women  had  a  higher
prevalence of coronary calcium than white women. In addition, Asian men and
women had a lower prevalence of coronary calcium, and the prevalence in Hispanics
was similar to the whites20
                The utility of CAC screening has also been investigated in special subsets of
populations such as women, diabetic patients and elderly .Two original investigations
and one meta analysis supported the utility of CAC for risk stratification in women.
The authors’ group11 compared the occurrence of all-death in approximately 4000
women and 6000 men referred for CAC screening by primary vary physicians.
CAC scores  were  lower  in  women than  in  the  men (p<.001),  but  death  rates
were higher among the older, diabetic, hypertensive and smoking patients of both the
gender.   .In risk adjusted models;  women had a greater probability of death than the
men for the CAC score importantly. CAC score added incremental prognostic value
to the FRS (p<.0001) in both the genders.
             Lakoski and colleagues conducted gender analyses of the Multi Ethnic Study
of Atherosclerosis (MESA) data and noted that a CAC score greater than 0 was strong
predictor of coronary heart and CVD events in 2684 women considered to be at low
risk  by  Framingham  categories  compared  with  patients  without  CAC  (hazard  ratios
6.5and 5.2 respectively) finally in a meta-analysis of three prospective and two
observational registries. Bellasi and his colleagues concluded that CAC screening is
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Figure - 9 showing types of AMI and vessels involved in GROUP I. 
 
 
 
 
 
 
 
 
 
 
 
Figure - 10 showing correlation of Mean Age and CACS in both groups. 
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equally accurate in stratifying risk for all-cause death and CVD events in women and
in men.
                There are only limited no of female patients involved in our study because
of social reasons as many of our female patients are not willing to enroll in our study.
In our study there are only 4 female in Group I and 5 female in Group II. There is no
positive correlation of CAC score in males compared to females in both groups.
Calcium Score in the Elderly:
                Age is an important predictive factor for coronary artery calcification in our
study independent of CAG lesions. Several recent cohorts have been published
including prospective observational registries in predominantly male, younger and
middle-aged , unselected and older-aged, higher risk  asymptomatic cohorts8 .
              For age group   40 to 49 and 50 to 59 years, a total score of 50 resulted in a
sensitivity of 71% and 74% and a specificity of 91% and 70%, respectively. For age
group 50 to 59 years, a total score of 300 gave a sensitivity of 74% and a specificity
of 81%.
               CAC  maintains  its  utility  for  risk  stratification  in  the  elderly.  In  the
prospective Rotterdam study, 2013 participants (mean age: 71+_5.7 years) received
CAC screening   and measurement of traditional cardiovascular risk factors23.
                 Men and women in the highest CAC score category showed an adjusted
odd ratio for myocardial infarction of 7.7 (95%cl:4.1-14.5) and 6.7( 95%cl:2.4-19.1 ),
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respectively, compared with the lowest score category (0-100). The predictive power
of CAC was independent of FRS category (low, intermediate or high).
                  Raggi and colleagues followed 35,388 patients ,with 3570 subjects being
70  years  of  age  or  older  at  screening  ,  for  an  average  period   of  5.8+_3 years  .The
author ‘s group11 reported an expected increase in all cause mortality rate  with
increasing age.
(relative hazard per age decline increase =1.09,95% cl;1.08-1.10 ;p<.000).
With higher death rates among men than women nonetheless, increasing CAC
score were associated with decreasing survival rates across all age declines ( p<.0001)
suggesting that CAC is evident even in the elderly. Finally using CAC score
categories,  more  than  40% of  elderly  patients  were  reclassified  into  lower  or  higher
risk categories compared with their original FRS group.
In our study the mean age is 50.82 in Group I and showed a significant
association with increased CAC score with statistical significance. (P- 0.025)
In Group II the mean age of the population 50.82 and showed a significant
association with increased CAC score with statistical significance (P- 0.006). And this
matches with the above mentioned various international studies.
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Calcium Score in Diabetic patients:
Several clinical studies have shown that glucose intolerance and insulin
resistance are associated with increased prevalence of CAC. Similarly frank diabetes
is  associated  with  a  greater  risk  of  CAC  compared  with  those  in  non-diabetic
population .Wong and colleagues and Anand and  colleagues 22demonstrated an
increasing incidence of inducible ischemia on stress myocardial perfusion imaging in
diabetic patients with a greater amount of CAC.
               Type  2  diabetic  patients  with  a   CAC  score  of  10  or  less,11  to100,101  to
400,401 to 1000,and greater than 1000 had an incidence of myocardial ischemia of
0%,18%,23%,48%,71%respectively,and morbidity and mortality increased
proportionally with CAC score and ischemic burden In an observational registry.
             Raggi and his colleagues showed a higher all- cause mortality rate for any
extent of CAC for diabetic subjects than the non-diabetic patients (p>.0001). Of
interest the 5- year mortality rate of diabetic patients with little or no CAC
(approximately 30% cohort of 903 diabetic patients )was as low as that of non-
diabetic subjects without CAC (approximately 1% at the end of the follow up).13
It is not an important predictive factor for coronary artery calcification in our
study independent of CAG lesions. However, Raggi et al. found that coronary calcium
predicted all-cause mortality in diabetics referred for fast coronary CT scanning.
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Figure- 7 showing relationship of HT with CACS among both groups. 
 
 
 
 
 
 
 
 
 
 
 
Figure-8 showing significance of CACS and Family history among both 
the groups. 
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Figure-5 showing significance of Smoking and CACS among both groups. 
 
 
 
 
 
 
 
 
 
 
 
Figure- 6 showing relationship of Diabetes with CACS in both groups. 
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            Raggi et al. also found that patients with diabetes have a greater increase in
risk for mortality associated with a given degree of calcium than the non-diabetic
patients Diabetic patients without any evidence of coronary calcification have a
survival rate similar to non-diabetic patients with a zero calcium score during 5 years
of follow-up.
            These results suggest that coronary calcium might be useful to further stratify
short-term risk in diabetic patients. However, until studies from non-referral
populations with longer follow-up, including fatal and non-fatal cardiovascular events
are completed, CAC scores should not be used to modify treatment goals in diabetic
patients.
            In Group I there are 12 diabetics (24%) with 9 cases (18%) showing positive
CAC and 3 cases (6%) showing negative CAC with a good statistical significance.
Hence  diabetes  showed  a  significant  association  with  CAC  in  patients  with
obstructive CAD with statistical significance (P- 0.06)
            In Group II there are 10 diabetics (20%) with 7 (14%) cases showing positive
CAC and 3 (6%) cases showing negative CAC with no statistical association. Hence
diabetes showed no significant association with CAC in patients with non obstructive
CAD (P- 0.11). And this matches in certain aspects with the above mentioned various
international studies
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CAC Score and Multivessel involvement:
            The CAC score was analyzed by multiple regression analysis between double
and triple vessel involvement with that of single vessel disease. It was found that there
is  no  increase  in  either  the  positivity  or  the  degree  of  CAC  score  with  multivessel
involvement when compared to single vessel disease.
 Incidental findings in patients undergoing CAC Testing:
Coronary calcium measurement by fast CT scanning of the heart includes
imaging of a portion of the lungs, mediastinum, bones and upper abdomen, in addition
to the aorta.
            The identification of potential pathology other than coronary calcium must be
considered when evaluating the benefits and costs of cardiac CT scanning. The most
common incidental finding is pulmonary nodules9 but in our study we found few
aortic, pulmonary artery and pulmonary vein calcification
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CONCLUSION
1) Sixty  four  slice  MDCT  derived  CAC  score  is  a  useful  tool  to  assess
angiographic severity in Post MI population.
2) CAC scores showed good correlation in patients with obstructive CAD
especially in Elderly, Diabetics and in those with a family history of CAD.
3) There is less correlation of CAC score with regards to other conventional risk
factors like Gender, Hypertension and Smoking in both obstructive and non
obstructive CAD.
4) CAC score was not useful to identity infarct related artery.
5) There was no linear correlation between CAC score and the number of vessel
involvement.
6) There was a significant negative correlation in hypertensive patients among
non obstructive CAD population.
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LIMITATIONS OF THE STUDY
1) There are only limited no of female patients involved in our study as many of our
female patients are not willing to undergo coronary angiogram.
2)  IVUS which is the gold standard is not performed to study the extent of accurate
plaque burden for comparison.
3) CAC scores in patients with renal disease could not be studied as there is risk in
CAG regarding contrast usage.
4) We  have  not  followed  the  patients  for  analysis  regarding  the  prognostic
implications of CAC scores.
5) CAC score is not analyzed in patients with acute coronary syndrome and chronic
stable angina.
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PROFORMA
 NAME:                                                    AGE/SEX:                                   DOA:
ADDRESS:
OCCUPATION:
                                                                                                                        DO AMI:
                                                                                                                        DO CAG:
                                                                                                                        DO CAC:
CAG NO:
DIAGNOSIS:
RISK FACTORS:
DM:                                             HT:                                              SMOKING:
DYSLIPIDEMIA:
                                          TC:                      LDL:                          TGL:
HDL:
FAMILY H/O CAD:                                                                     CKD:
CAC SCORE:
CAG FINDINGS:
                             LM:
                             LAD:
                             LCX:
                             RCA:
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GLOSSARY AND ACRONYMS
AMI- Acute Myocardial Infarction.
AWMI- Anterior Wall Myocardial Infarction.
IWMI- Inferior Wall Myocardial Infarction.
RVMI- Right Ventricular Myocardial Infarction.
LWMI- Lateral Wall Myocardial Infarction.
CAD- Coronary Artery Disease.
CAC-coronary artery calcium.
LAD- left anterior descending artery.
LCX- left circumflex artery.
RCA- right coronary artery.
OM-obtuse marginal, D-diagonal artery.
STEMI- ST segment Elevation Myocardial Infarction.
LVEF- Left Ventricular Ejection Fraction.
EBCT- Electron Beam Computed Tomography.
MDCT- Multirow Detector Computed Tomography.
MRI-Magnetic Resonance Imaging.
ECG- Electrocardiogram.
ECHO- Echocardiogram.
S.N
O NAME
AGE/
SEX IP NO DIAGNOSIS
CAG
NO D.O.MI D.O.CAG
D.O.CA
C
LAD
CAG
LCX
CAG
RCA
CAG
LAD
CAC
LCX
CAC
RCA
CAC
TOTAL
CAC DM HT
SMOKI
NG
FAMILY
H/O CAD
1 PARAMASIVAM M/58 24180 OLD AWMI 1280 10/2/10 29/02/10 2/5/10 70 0 0 87 34 0 122 NIL NIL NIL NIL
2 RAJENDRAN 48/M 474 OLD IWMI 1041 17/1/10 22/1/10 15/2/10 0
90 0
8.87
0 0
8.87 NIL NIL YES NIL
3 ABUBEKAR 50/M 3147 OLD IWMI 1046 12/1/10 22/1/10 28/4/10 0 0 100 0 0 0 0 NIL NIL NIL NIL
4 SRINIVASAN 50/M 70238 OLD AWMI 599 31/7/09 12/9/09 12/4/10
70 0 90
108.32 0 0 108.32 YES YES YES NIL
5 VELMURUGAN 42/M 9237 OLD IWMI 1088 16/5/09 6/2/10 11/3/10 0 0 100 0 0 0 0 NIL NIL YES NIL
6 SELVAPANDIAN 49/M 64559 OLD AWMI 521 8/5/09 24/8/09 1/4/10 50 0 70 0 0 0 0 YES NIL NIL NIL
7 RADHAKRISHNAN 57/M 24502 OLD AWMI 1350 10/2/10 31/3/10 5/4/10 60 0 30 21 10 1 33 NIL NIL YES NIL
8 MALLIGA 63/F 6210 OLD IWMI 1205 24/1/10 6/3/10 10/4/10 70 0 70 95 0 314 409 YES NIL NIL NIL
9 NARAYANAN 62/M 21555 OLD AWMI 1295 10/1/10 20/3/10 1/4/10 90 0 0
0 0 0 0
NIL NIL NIL NIL
10 KUMAR 40/M 8400 OLD IWMI 1021 11/9/09 18/1/10 22/2/10 60 0 150 0 0 0 0 YES YES NIL NIL
11 NAGARAJAN 47/M 27158 OLD IWMI 1410 28/1/10 12/4/10 16/4/10 0 50 70 0 0 0 0 NIL NIL YES NIL
12 ARUMUGAM 37/M 70115 OLD AWMI 719 3/8/08 6/10/09 23/4/10 50 0 70 0 0 0 0 NIL YES NIL NIL
13 RADHAKRISHNAN 53/M 18125
OLD AWMI
1351 6/3/10 31/3/10 1/4/10 60 0 30 21 26 0 47 NIL YES NIL NIL
14 LOGANATHAN 45/M 15777 OLD IWMI 444 20/4/09 3/8/09 2/2/10 0 40 100 47 73 148 269 YES YES YES NIL
15 RAJENDRAN 48/M 474 OLD IWMI 1041 24/1/05 22/1/10 25/3/10 0 90 0 0 0 0 0 NIL YES YES NIL
16 NIRMALA 39/F 98983
OLD AWMI
923 16/1/09 19/12/09 7/2/10 70 70 0 27 0 0 27 NIL NIL NIL NIL
17 KRISHNAN 61/M 35469 OLD AWMI 1124 14/1/09 13/2/10 6/3/10 40 0 40 0 O 0 0 YES YES YES NIL
18 KANNIYAPPAN M/63 363 OLD IWMI 389 12/5/09 14/7/09 14/3/10 0 99 0 156 7 15 178 NIL YES NIL NIL
19 ISAAC 57/M 3779
OLD AWMI
1031 17/01/10 20/01/10 20/03/10 90 0 0 0 0 0 0 NIL YES NIL NIL
20 JAYASHANKER 37/M 6614 OLD AWMI 1071 18/12/09 27/01/10 2/4/10 70 0 0
0 0 0 0 NIL NIL NIL NIL
21 MANI 69/M 82592 OLD AWMI 924 25/5/09 19/12/09 8/3/10 40 80 70 0 0 0 0
NIL NIL NIL NIL
22 MOHAMMED IBRAIM 57/M 14008 OLD AWMI 1179 12/12/09 24/02/10 13/4/10 70 0 90 0 0 0 0
NIL NIL NIL NIL
23 ELLANGOVAN 49/M 18611 OLD AWMI 1255 22/1/10 12/3/10 7/4/10 70 0 0
0 0 0 0 NIL NIL NIL NIL
24 RUKRUDEEN 50/M 23234 OLD AWMI 1283 16/1/10 29/02/10 3/4/10 90 0 0 26 0 0 26 YES YES NIL NIL
MASTER CHART OF GROUP I POPULATION
25 DEVARAJAN 69/M 19054 OLD AWMI 1260 15/12/09 13/03/10 25/4/10 40 70 0 0 0 0 0
NIL NIL NIL NIL
26 RAMALINGAM 68/M 17060 OLD IWMI 1261 1/1/10 13/03/10 22/4/10 0 0 80 166 18 5 189
NIL NIL NIL NIL
27 KANTHASWAMI 60/M 17051 OLD AWMI 1262 6/1/10 13/03/10 17/4/10 90 0 0 137 0 0 137
NIL NIL NIL YES
28 VASANTHA 49/F 19049 OLD AWMI 1263 28/12/09 13/03/10 19/4/10 70 30 0
0 0 0 0 NIL YES NIL NIL
29 NALLANKILLI 42/F 19302 OLD IWMI 1280 3/1/10 15/03/10 3/4/10 90 0 0 0 0 0 0
NIL NIL NIL NIL
30 MOHMAD IBRAHIM M/57 14008 OLD AWMI 1180 21/2/10 24/2/10 2/4/10 70 0 90 37 60 98 195
YES NIL YES NIL
31 ARUMUGAN 40/M 18053 OLD AWMI 1290 26/1/10 17/03/10 29/4/10 100 0 0 0 0 0 0
NIL NIL NIL NIL
32 GOKULAKANNAN 35/M 19079 RESENT AWMI 1296 14/1/10 20/03/10 12/4/10 30 100 40 0 0 0 0
NIL NIL NIL NIL
33 ANANDHI 26/F 19182 OLD AWMI 1500 10/3/10 3/5/10 13/5/10 90 50 0 0 0 0 0 NIL YES NIL NIL
34 JAYARAMAN 52/M 23962 OLD AWMI 1285 4/1/10 30/3/10 14/9/10 100 100 70 237 60 148 445 NIL NIL NIL NIL
35 BABU 55/M 23191 OLD AWMI 1040 19/11/09 22/1/10 27/3/10 0 0 80 16 1 1 18 NIL NIL YES YES
36 KUMAR 40/M 3400 0LD IWMI 1025 2/1/10 18/1/10 23/3/10 80 0 100 221 152 19 393 NIL YES NIL NIL
37 PRABAKAR 46/M 10192 OLD AWMI 1181 12/12/09 20/03/10 12/5/10 100 0 0 20 6 85 111 NIL NIL NIL NIL
38 RAJU 59/M 24460 OLD AWMI 1352 3/1/10 31/3/10 1/4/10 0 0 70 237 60 148 445 NIL NIL YES NIL
39 KRISHNAN 61/M 35469 REC AWMI 273 14/1/09 12/5/09 17/5/10 40 100 40 17 1 1 20 Y Y YES NIL
40 KANNIYAPPAN 63/M 51219 OLD IWMI 390 10/10/08 14/7/09 14/5/10 70 99 0 156 7.5 15.1 178.6 NIL NIL YES NIL
41 ARJUN 32/M 4697 OLD AWMI 1042 24/1/08 22/1/10 27/3/10 70 0 0 0 0 0 0 NIL NIL YES NIL
42 ARUMUGA37M 37/M 70115 OLD IWMI 692 3/8/08 6/10/09 23/4/10 50 0 70 0 0 0 0 NIL NIL NIL NN
43 JAYACHANDRAN 46/M 10100 OLD AWMI 270 12/12/09 11/5/09 12/5/10 100 0 0 0 0 0 0 NIL NIL NIL NIL
44 KUMAR 25/M 10188 OLD AWMI 1305 13/1/10 22/3/10 26/4/10 70 0 0 0 0 0 0 NIL NIL NIL NIL
45 MOHAMMED SHERIF 48/M 23192 OLD AWMI 1383 13/2/10 7/4/10 8/4/10 70 70 60 0 3 0 3 YES NIL YES YES
46 ANANDHAN M/66 4573 RECENT IWMI 1445 23/3/10 19/4/10 23/4/10 80 75 90 17 1 1 20 YES NIL NIL NIL
47 RAMACHANDRAN M/55 42165 OLD AWMI 777 5/8/09 23/10/09 2/4/10 70 70 60 2 0 0 2 NIL NIL NIL NIL
48 SOMAN 59/M 25598 OLD AWMI 1385 10/2/10 7/4/10 8/4/10 80 50 0 254.64 9.39 139 403.43 NIL NIL NIL NIL
49 VELVENDRAN M/63 23190 OLD AWMI 1384 1/2/10 7/4/10 8/4/10 90 0 0 422 0 15 438 NIL NIL NIL NIL
50 GOPAL M/57 24453 OLD AWMI 1425 4/1/10 15/4/2010 17/4/10 90 0 70 488 0 5 493 YES YES YES YES
S.N
O NAME
AGE/
SEX IP NO DIAGNOSIS
CAG
NO D.O.MI D.O.CAG D.O.CAC
LAD
CAG
LCX
CAG
RCA
CAG
LAD
CAC
LCX
CAC
RCA
CAC
TOTAL
CAC DM HT
SMO
KIN
FAMILY
H/O CAD
1 VASUDEVAN 44/M 19111 OLD AWMI 1291 11/2/10 17/03/10 3/4/10 0 0 0 12 0 0 12 YES NIL NIL NIL
2 VEERiAH 49/M 15328 OLD AWMI 768 14/10/09 21/10/09 3/4/10 0 0 0 0 0 0 0 NIL NIL YES NIL
3 RAVICHANDRAN 50/M 12002 OLD AWMI 1144 9/11/09 17/2/10 13/4/10 0 0 0 0 0 0 0 YES YES NIL NIL
4 KRISHNAMOORT 48/M 781578 OLD AWMI 1082 14/10/09 29/1/10 2/2/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
SUBRAMANI 41/M 23208 OLD AWMI 1085 20/1/10 6/2/10 5/510 0 0 0 0 0 0 0 NIL NIL NIL NIL
BASKAR 68/M 54679 0LD AWMI 1294 20/3/10 31/3/10 3/4/10 20 0 0 1573 0 37 1610 NIL NIL NIL NIL
7 THANGARAJ M/39 98890 0LD AWMI 919 30/9/09 19/12/09 12/5/10 0 0 40 14.94 0 0 14.94 NIL NIL YES NIL
8 RAJU 59/M 24460 OLD IWMI 1353 17/12/09 31/3/10 1/4/10 0 30 0 160.6 25.5 206.3 392.5 NIL NIL NIL NIL
9 RATHNAM 60/M 100964 OLD AWMI 1088 23/1/10 6/2/10 5/510 0 0 0 0 0 0 0 NIL NIL YES NIL
5
MASTER CHART OF GROUP II POPULATION
10 ARJUN 34/M 4196 OLD AWMI 1031 25/2/08 19/1/10 26/4/10 0 0 0 252 40 130 423 NIL NIL NIL NIL
11 JAYACHANDRAN 50/M 10152 OLD IWMI 1145 26/12/09 17/2/10 5/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
12 KUPPAN 55/M 29709 OLD IWMI 63 26/12/09 21/4/09 25/4/10 0 0 0 0 0 0 0 NIL NIL YES NIL
13 ANSARI M/32 4697 OLD AWMI 1043 20/1/10 22/1/10 16/3/10 0 0 0 0 0 0 0 NIL YES NIL NIL
14 RAMESH 20/M 25346 OLD AWMI 1379 19/12/09 6/4/10 26/4/10 0 0 0 542 0 304 846 NIL NIL NIL NIL
15 PERUMAL 53/M 25344 OLD AWMI 1378 3/1/10 6/4/10 24/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
16 DANAPAL 61/M 26051 OLD AWMI 1377 19/12/09 7/4/10 12/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
17 JOSEPH 62/M 24829 OLD IWMI 1376 6/1/10 6/4/10 20/4/10 0 0 0 0 0 0 0 NIL YES NIL NIL
18 MOHMEED 45/M 26331 OLD AWMI 1391 7/12/09 9/4/10 13/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
19 GANESH 48/M 26337 OLD AWMI 1392 7/1/10 9/4/10 26/4/10 0 0 0 12 0 59 71 YES NIL NIL NIL
20 SHANKAR 55/M 26345 RECENT
IWMI
1393 22/12/09 9/4/10 17/4/10 0 0 0 0 0 2 2 NIL YES NIL NIL
21 NATARAJAN 38/M 24751 OLD AWMI 1396 4/11/09 10/4/10 21/4/110 0 0 0 0 0 0 0 NIL NIL NIL NIL
22 MURUGASEN 61/M 26778 RECENT 1397 17/8/09 10/4/10 18/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
23 RAJI 50/F 26806 OLD AWMI 1398 20/12/09 10/4/10 17/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
24 LALITHA 36/F 27160 OLD IWMI 1405 18/1/10 12/4/10 19/4/10 0 40 0 0 0 0 0 NIL NIL NIL NIL
25 NAGARAJAN 47/M 27158 OLD IWMI 1406 28/1/10 12/4/10 16/4/10 0 0 0 12 14 0 26 YES NIL NIL NIL
26 KALAISELVI 55/F 27159 OLD IWMI 1407 13/2/10 12/4/10 23/4/10 0 0 0 12 2 0 14 NIL NIL NIL NIL
27 MANOGARAN 45/M 25141 OLD AWMI 1408 11/1/10 12/4/10 24/4/10 0 0 0 0 0 0 0 NIL YES NIL NIL
28 ANBU 33/M 18189 OLD AWMI 1224 26/1/10 11/3/10 27/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
29 SUNTHARAM 45/M 18410 OLD IWMI 1225 11/1/10 11/3/10 21/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
30 VEERAN 28/M 18786 OLD IWMI 1226 12/1/10 11/3/10 2/4/10 0 0 0 2 0 0 0 NIL YES NIL NIL
31 ARJUNAN 45/M 18188 OLD AWMI 1227 27/12/09 11/3/10 18/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
32 ARJUN 34/M 4196 OLD AWMI  1032 25/2/08 19/1/10 26/4/10 0 0 0 0 0 0 0 YES NIL NIL NIL
33 IRUTHYARAJ 51/M 20830 OLD IWMI 1263 12/2/10 20/03/10 2/4/10 30 0 0 0 0 0 0 NIL NIL NIL NIL
34 SELVARAJ 55/M 21237 OLD AWMI 1267 13/1/10 22/03/10 9/4/10 0 0 0 0 0 0 0 YES YES NIL NIL
35 DOSS 40/M 21433 OLD IWMI 1270 11/1/10 23/03/10 29/4/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
36 PRABAGARAN 46/M 21434 OLD IWMI 1271 23/12/09 23/03/10 28/3/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
37 SARAVANAN 45/M 20983 OLD AWMI 1274 10/2/10 23/03/10 28/3/10 0 0 40 21 0 0 21 YES NIL NIL NIL
38 KUMAR 56/M 21679 OLD AWMI 1275 13/12/09 24/03/10 28/3/10 0 0 0 0 0 0 0 NIL NIL NIL NIL
39 SRINIVASAN 56/M 21665 OLD IWMI 1276 1/2/10 24/03/10 28/3/10 0 0 0 31 0 12 43 YES NIL NIL NIL
39 SRINIVASAN 56/M 21665 OLD IWMI 1276 14/2/2010 24/03/10 28/3/10 0 0 0 342 0 34 376 NIL NIL YES NIL
40 SULTHAN 63/M 21431 OLD IWMI 1272 9/1/10 24/03/10 1/4/10 0 0 30 542 0 304 846 NIL NIL NIL YES
41 BABU 58/M 23191 OLD AWMI 1193 19/11/09 29/02/10 2/3/10 O 0 0 57.25 52.4 11.27 120.92 NIL NIL NIL NIL
42 SOWKATH ALI 48/M 25641 OLD AWMI 1382 13/2/10 7/4/10 8/4/10 0 0 0 0 0 0 0 NIL YES NIL NIL
43 KUMAR 35/M 22907 RECENT AWMI 1194 5/1/10 29/02/10 14/4/10 0 0 0 83 1 304 388 NIL NIL NIL NIL
44 RATHAKRISHNAN 53/M 24502 OLD AWMI 1302 13/11/09 31/02/10 5/4/10 O O O 0 0 50 50 NIL NIL NIL NIL
45 PERUMAL 55/M 23949 OLD IWMI 1354 4/1/10 31/03/10 2/4/10 0 0 0 0 0 0 0 NIL YES NIL NIL
46 RAJENDRAN 50/M 13956 OLD IWMI 1305 19/12/09 31/02/10 14/3/10 0 0 0 0 0 25 25 YES NIL NIL NIL
47 VENI 56/F 24768 CAD AWMI 1364 9/1/10 3/4/10 15/4/10 0 0 0 12 14 0 26 NIL NIL NIL NIL
48 MUNISWAMI 60/M 25041 CAD AWMI 1365 24/1/10 3/4/10 23/4/10 0 0 0 0 0 0 0 NIL YES NIL NIL
49 ARUMUGAM 50/M 25156 OLD AWMI 1372 12/2/10 5/4/10 12/4/10 0 0 0 21 0 12 33 NIL NIL NIL NIL
50 NARAYANAN 62/M 21555 OLD IWMI 1264 14/1/10 20/3/10 1/4/10 0 0 0 0 0 0 0 YES NIL NIL NIL
